Search earnings tickers

LLY

2024Q3BMO

Eli Lilly and Company primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-10-30 · Fiscal end 2024-09-30 · Features as of 2024-10-29

← Earnings history

Street

Consensus EPS1.47

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.6%

IV front—

P/C full—

P/C front—

Features as of2024-10-29

Run-up

Close—

Ret 5d-0.6%

Ret 10d-1.1%

Ret 20d+2.2%

Ret 30d-0.3%

Print

Actual EPS

1.18Miss

Estimated EPS1.47

Actual revenue

11.4B

Surprise %-19.7%

Beat / missMiss

Beat streak 40

Beat streak 80

Reaction

1-day stock reaction+6.1%

Implied vs actual

Implied 2.6%Actual 11.6%

Gap reaction-11.6%

Day result-6.3%

Next-day upYes

Realized / IV4.46×

Post tape

Post 5d-8.3%

Post 10d-4.1%

Post volume18.3M

Vol ×10d8.67×

Vol ×20d8.80×

Post range11.5%

LLY

Pre-Earnings Data